Presentations and Publications

Resident Presentations and Publications

Abbas, Shan E:  Multifocal Myelinolysis after Rapid Correction of Hyperglycemia.  Abstract selected for poster presentation at the 61^st Annual Meeting of the American Academy of Neurology, Seattle, Washington, April 28, 2009. 

James, E:  An Interesting Case of Non-Convulsive Status Epilepticus Initially Diagnosed as Depressive Episode with Catatonic Features, presented at the American Clinical Neurophysiology Society Annual Meeting, Orlando FL, March 7, 2009. 

Fouzia Siddiqui MD and Imran Ali MD; “Cumulative effect of Vagal Nerve Stimulator in intractable seizures observed over a period of three years.", has been accepted for poster presentation to the American Academy of Neurology for the Annual Meeting April 2009.

Vetteth S, Sehgal S.:  Unusual late Leukocytoclastic Vasculitic presentation of Poison Oak exposure.   Selected for poster presentation competition at the Annual 2008 ACP Internal Medicine held in Washington DC.

Hafeez F, Levine R.L, Razzaq M.A, Ramirez MA:  Reperfusion seizures, Journal of Stroke and Cerebrovascular diseases, November 2007.

Ali II, Herial NA, Pirzada NA, Kaplish N, Greenfield LJ.  Non-convulsive status epilepticus in patients with hypoxic-ischemic encephalopathy:  Electroencephalographic features and outcome.  Epilepsia 2005, 46 (Suppl. 8):131 (abstract 2.120).

Tietjen GE, Nicholas S, Herial NA. High Prevalence of Stroke Risk Factors in the Cook Islands.  Scientific Session. American Academy of Neurology Annual Meeting, April 2005.

Dafer R, Tietjen GE.  Antiphospholipid Antibody syndrome, Neurologic Complications.  In: The 5-Minute Neurology Consult. Lynn DJ, Newton HB, Rae-Grant AD (eds). Lippincott Williams & Wilkins. Philadelphia PA. 2004:66-67

Pirko I, Koffman B.  Prospective evaluation of the effects of intravenous immunoglobulin (IVIG) or intravenous methylprednisolone (IVMP) therapy on lymphocyte subpopulations.  Neurology 2001;56 (Suppl 3):A296.

Pirzada N, Medel M, Ali I. “Colchicine neuromyopathy in a patient with normal renal function” Accepted for Publication. Journal of Clinical Rheumatology. May 2001. Date of Publication, December 2001.

Tietjen GE, Al-Qasmi MM, Athanas K, Dafer RM, Khuder SA.  Increased von Willebrand factor in migraine.  Neurology 2001;57:334-36.

Pirzada N, Pirko I, Ali I.  Colchicine induced neuromyopathy. Muscle And Nerve 2000 23(10):1639

Ali I I, Yassine K, Schell C, Khuder S, Pirzada N: Topiramate induced weight loss in patients with Epilepsy: Post marketing experience from an Epilepsy Center. Neurology 2000:54(7):194-195

Pirzada N, Veerappan V, Ali I. Polyneuropathy: a rare complication of neurosarcoidosis., Neurology 2000:54 (7):448

Pirzada N, Ali I I, Dafer R. 5' FU associated neurotoxicity. Annals of Pharmacotherapy  34(1):35-38, 2000

Dafer R, Tietjen GE, Schell C, Ali I I: The frequency of headaches in patients with seizures. Headache 2000;40: 406

Dafer RM, Tietjen GE. Antiphospholipid Antibody Syndrome, Neurologic Complications. In: The 5 Minute Neurology Consult. Lynn J (ed). Lippincott William and Wilkins. Philadelphia. 2000:66-67.

Ali I I, Boulos M, Pirzada N. Utility of Brainstem Auditory Evoked Potential monitoring during microvascular decompression of the trigeminal nerve. Neurology 1999:52 (6) S2:A371

Dafer R, Tietjen GE, Asherson RA: Drug Treatment of stroke in patients with antiphospholipid antibodies. In: CNS Drugs, 1997, 8(3):219-226. Adis International Limited